Qube Research & Technologies (QRT)’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
Qube Research & Technologies (QRT)'s IPSC Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in Century Therapeutics (IPSC) in Q3 2026: 11,418 shares worth $19.5K. The stake represents ﹤0.01% of the portfolio and ranks #3447 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IPSC as recently as Q3 2025.
Qube Research & Technologies (QRT) first reported a position in IPSC in Q2 2021 and has held it in 7 quarters since. The position peaked at $586K in Q2 2021. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Qube Research & Technologies (QRT) held 11,418 shares of Century Therapeutics worth $19.5K as of Q3 2026.
- Century Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
- Century Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #3447 holding.
- Qube Research & Technologies (QRT) first reported a position in Century Therapeutics in Q2 2021 and has held it in 7 quarters since.
- Qube Research & Technologies (QRT)'s Century Therapeutics position peaked at $586K in Q2 2021.
- 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.